Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference51 articles.
1. International Conference on Harmonisation; Guidance on Q4B evaluation and recommendation of pharmacopoeial texts for use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice. Fed Regist. 2010;75:17148–9.
2. Suarez-Sharp S, Delvadia PR, Dorantes A, Duan J, Externbrink A, Gao Z, et al. Regulatory perspectives on strength-dependent dissolution profiles and biowaiver approaches for immediate release (IR) oral tablets in new drug applications. AAPS J. 2016;18:578–88. https://doi.org/10.1208/s12248-016-9893-2.
3. Langer C, Diaz DA, Van Alstine L, Bandi N, Fitzgerald S, Colgan S. Analysis of the regulatory divergence of comparative dissolution requirements for post-approval manufacturing changes of modified release solid oral dosage forms. AAPS J. 2019;22:2. https://doi.org/10.1208/s12248-019-0383-1.
4. Abend AM, Zhang L, Fredro-Kumbaradzi E, Hoffelder T, Cohen MJ, Anand O, et al. Current approaches for dissolution similarity assessment, requirements, and global expectations. AAPS J. 2022;24:50. https://doi.org/10.1208/s12248-022-00691-4.
5. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) M9: Biopharmaceutics classification system-based biowaiver. Available from: https://www.ich.org/page/multidisciplinary-guidelines. Accessed 7 Sept 2023.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献